2019 DIA Editor’s Take – Oracle

Thought Leader:

Bruce Palsulich, Global VP of Product Strategy, Oracle

July 31, 2019      

Bruce Palsulich discusses the impact AI will have on pharmacovigilance as well as other aspects of clinical trials and the industry at large.

For more information please visit www.pharmavoice.com/oracle.com/lifesciences.

Bruce Palsulich discusses the impact AI will have on pharmacovigilance as well as other aspects of clinical trials and the industry at large.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK